Sympathetic and Blood Pressure Responses to Aerobic Exercise and Guided Respiration in Hypertensives
1 other identifier
interventional
29
0 countries
N/A
Brief Summary
Hypertension is serious health problem in Brazil and affects almost 30%of adult population. It is known that there are pharmacologic and nonpharmacologic strategies for treating hypertension. Aerobic exercise and slow breathing are nonpharmacologic methods that reduce blood pressure in an isolated form, but its combinations has never been studied. The aim of this study is to evaluate the association of both strategies and also the mechanisms involved in blood pressure reduction using slow breathing, in stages 1 and 2 hypertensives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Jan 2011
Longer than P75 for not_applicable hypertension
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 7, 2015
CompletedFirst Posted
Study publicly available on registry
November 20, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedOctober 27, 2016
October 1, 2016
2.2 years
October 7, 2015
October 25, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood pressure reduction
The reduction in blood pressure in mmHg immediately after after a single session of the association of aerobic exercise and guided slow breathing and during 24 hours blood pressure monitoring (ABPM).
A session (1 day), after the placebo period of 30 days.
Secondary Outcomes (1)
Autonomic regulation
A session (1 day), after the placebo period of 30 days.
Study Arms (2)
Slow breathing group (GRL)
ACTIVE COMPARATORAfter randomization and have done aerobic exercise, patients allocated in this arm of the study, using the device-guided breathing - Slow breathing group (GRL), for 15 minutes during the experimental session.
Music group (GC)
PLACEBO COMPARATORAfter randomization and have done aerobic exercise, patients allocated in this study arm will hear slow music - Music group (GC), for 15 minutes during the experimental session.
Interventions
The device-guided breathing - Resperate®-InterCure Ltda, uses sound to guide and therefore reduce the respiration rate in individuals.
The patients in this arm will hear slow music - Music group (GC).
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 60 years, of both sexes not obese (BMI \<30 kg / m2);
- Sedentary not to perform physical exercise for at least three months;
- Hypertensive without target organ damage or untreated stage I and stage II (SBP 140-179 mmHg and DBP 90-109 mmHg) after four weeks with the use of placebo and without comorbidities; What would agree to participate in the study by signing the Instrument of Consent;
You may not qualify if:
- Patients who presented blood pressure greater than 180/100 mmHg at any rate during the home monitoring of blood pressure and they needed treatment with active drug;
- White-coat hypertension, or persistently elevated BP measurements (≥ 140/90 mmHg) in the office and BP means be considered normal in HBPM or ABPM.
- Masked Hypertension, or high blood pressure office \<140/90 mmHg, and 24-hour ABPM with daytime BP\> 130/85 mmHg;
- Patients with a history of alcoholism, drug abuse or mental disorders that could invalidate the consent, or limit the patient's ability to comply with the rules of the Protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Post graduate
Study Record Dates
First Submitted
October 7, 2015
First Posted
November 20, 2015
Study Start
January 1, 2011
Primary Completion
March 1, 2013
Study Completion
December 1, 2015
Last Updated
October 27, 2016
Record last verified: 2016-10